CXCL13 expression has also been reported to be upregulated by interleukin 6 (IL-6) through an unknown mechanism, which may be significant in BM-PCa, as IL-6 levels are observed to be higher in PCa patients with bone metastases ( 128 , 132 , 133 ).
1
—
—